Prime Medicine (PRME) EBITDA Margin (2024 - 2026)
Prime Medicine (PRME) reported EBITDA Margin of 5748.25% for Q1 2026, down 217837.0% on a YoY basis from N/an in Q1 2025, and down 4.65% quarter-over-quarter from 5492.84% in Q4 2025.
Prime Medicine (PRME) EBITDA Margin (2024 - 2026) Analysis & Trends
Prime Medicine has reported EBITDA Margin for 3 years, with the latest figure at 5748.25% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 217837.0% year-over-year to 5748.25%; the trailing twelve-month figure through Mar 2026 stood at 4917.2% (up 33321.0% YoY), and the FY2025 full-year result was 4340.7%, up 222538.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 5748.25%, down from 5492.84% in the prior quarter.
- The five-year high for EBITDA Margin was 1937.52% in Q4 2024, with the low at 25084.21% in Q3 2024.
- Historically, EBITDA Margin has averaged 7303.88% across 3 years, with a median of 5104.54% in 2025.
- The largest YoY upside for EBITDA Margin was 2095858 bps in 2025 against a maximum downside of 355532 bps in 2025.
- Prime Medicine's EBITDA Margin stood at 1937.52% in 2024, then plunged by 183 bps to 5492.84% in 2025, then slipped by 5 bps to 5748.25% in 2026.
- The last three EBITDA Margin figures came in at 5748.25% (Q1 2026), 5492.84% (Q4 2025), and 4125.63% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prime Medicine | 572.02 Mn | 572.02 Mn | - | -5,748.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,748.25% |
| Dec 31, 2025 | -5,492.84% |
| Sep 30, 2025 | -4,125.63% |
| Jun 30, 2025 | -4,716.23% |
| Mar 31, 2025 | -3,569.88% |
| Dec 31, 2024 | -1,937.52% |
| Sep 30, 2024 | -25,084.21% |
| Mar 31, 2024 | -7,756.51% |